PT Bank Mandiri (Persero) Tbk

IDX:BMRI Stock Report

Market Cap: Rp613.7t

Bank Mandiri (Persero) Valuation

Is BMRI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BMRI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BMRI (IDR6575) is trading below our estimate of fair value (IDR6764.21)

Significantly Below Fair Value: BMRI is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BMRI?

Key metric: As BMRI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for BMRI. This is calculated by dividing BMRI's market cap by their current earnings.
What is BMRI's PE Ratio?
PE Ratio10.6x
EarningsRp58.01t
Market CapRp613.67t

Price to Earnings Ratio vs Peers

How does BMRI's PE Ratio compare to its peers?

The above table shows the PE ratio for BMRI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average16.2x
BBRI Bank Rakyat Indonesia (Persero)
11x9.2%Rp673.4t
BBCA Bank Central Asia
23.5x9.4%Rp1254.3t
BBNI Bank Negara Indonesia (Persero)
8.7x12.5%Rp185.9t
BRIS Bank Syariah Indonesia
21.7x17.7%Rp136.1t
BMRI Bank Mandiri (Persero)
10.6x9.0%Rp613.7t

Price-To-Earnings vs Peers: BMRI is good value based on its Price-To-Earnings Ratio (10.6x) compared to the peer average (16.2x).


Price to Earnings Ratio vs Industry

How does BMRI's PE Ratio compare vs other companies in the ID Banks Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
BMRI 10.6xIndustry Avg. 20.6xNo. of Companies9PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: BMRI is good value based on its Price-To-Earnings Ratio (10.6x) compared to the ID Banks industry average (20.4x).


Price to Earnings Ratio vs Fair Ratio

What is BMRI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BMRI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio10.6x
Fair PE Ratio10.6x

Price-To-Earnings vs Fair Ratio: BMRI is expensive based on its Price-To-Earnings Ratio (10.6x) compared to the estimated Fair Price-To-Earnings Ratio (10.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BMRI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRp6,575.00
Rp8,014.05
+21.9%
7.2%Rp9,500.00Rp6,920.00n/a22
Nov ’25Rp6,650.00
Rp8,008.59
+20.4%
7.3%Rp9,500.00Rp6,800.00n/a22
Oct ’25Rp7,050.00
Rp7,861.45
+11.5%
6.7%Rp9,150.00Rp6,800.00n/a22
Sep ’25Rp7,125.00
Rp7,730.96
+8.5%
7.4%Rp9,150.00Rp6,800.00n/a23
Aug ’25Rp6,750.00
Rp7,408.13
+9.8%
7.1%Rp9,150.00Rp6,800.00n/a23
Jul ’25Rp6,250.00
Rp7,400.71
+18.4%
6.1%Rp8,600.00Rp6,800.00n/a24
Jun ’25Rp5,900.00
Rp7,407.38
+25.5%
6.0%Rp8,600.00Rp6,800.00n/a24
May ’25Rp6,900.00
Rp7,586.28
+9.9%
7.3%Rp8,600.00Rp6,200.00n/a25
Apr ’25Rp6,900.00
Rp7,497.48
+8.7%
7.6%Rp8,600.00Rp6,200.00n/a25
Mar ’25Rp7,025.00
Rp7,404.68
+5.4%
6.9%Rp8,300.00Rp6,200.00n/a25
Feb ’25Rp6,550.00
Rp7,068.92
+7.9%
7.8%Rp8,150.00Rp5,900.00n/a25
Jan ’25Rp6,050.00
Rp6,639.71
+9.7%
6.0%Rp7,700.00Rp5,900.00n/a24
Dec ’24Rp5,900.00
Rp6,613.74
+12.1%
5.8%Rp7,700.00Rp5,900.00n/a23
Nov ’24Rp5,650.00
Rp6,590.70
+16.6%
6.2%Rp7,700.00Rp5,630.00Rp6,650.0023
Oct ’24Rp6,025.00
Rp6,563.52
+8.9%
7.5%Rp7,700.00Rp5,200.00Rp7,050.0023
Sep ’24Rp6,075.00
Rp6,528.74
+7.5%
6.5%Rp7,500.00Rp5,200.00Rp7,125.0023
Aug ’24Rp5,650.00
Rp6,298.30
+11.5%
9.0%Rp7,500.00Rp5,200.00Rp6,750.0023
Jul ’24Rp5,200.00
Rp5,959.65
+14.6%
7.1%Rp6,900.00Rp5,200.00Rp6,250.0023
Jun ’24Rp5,050.00
Rp5,915.00
+17.1%
7.3%Rp6,900.00Rp5,200.00Rp5,900.0023
May ’24Rp5,175.00
Rp5,918.13
+14.4%
7.0%Rp6,900.00Rp5,250.00Rp6,900.0024
Apr ’24Rp5,162.50
Rp5,889.98
+14.1%
7.0%Rp6,900.00Rp5,250.00Rp6,900.0024
Mar ’24Rp5,050.00
Rp5,884.77
+16.5%
7.0%Rp6,900.00Rp5,250.00Rp7,025.0024
Feb ’24Rp4,850.00
Rp5,813.94
+19.9%
7.8%Rp6,750.00Rp4,650.00Rp6,550.0024
Jan ’24Rp4,962.50
Rp5,697.08
+14.8%
8.4%Rp6,750.00Rp4,650.00Rp6,050.0024
Dec ’23Rp5,200.00
Rp5,612.50
+7.9%
8.1%Rp6,600.00Rp4,650.00Rp5,900.0022
Nov ’23Rp5,200.00
Rp5,498.91
+5.7%
8.9%Rp6,300.00Rp4,200.00Rp5,650.0023

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies